The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II randomized study of maintenance therapy with regorafenib (REGO) versus placebo after first-line platinum and fluoropyrimidines-based chemotherapy in HER2 negative locally advanced/metastatic gastric (GC) or gastroesophageal junction (GEJ) cancer: Results of a-MANTRA study (GOIRC-05-2016).
 
Angela Damato
Travel, Accommodations, Expenses - Incyte; Ipsen; Janssen-Cilag; Lilly
 
Domenico Bilancia
No Relationships to Disclose
 
Francesco Iachetta
No Relationships to Disclose
 
Antonia Strippoli
No Relationships to Disclose
 
Francesca Filiali
No Relationships to Disclose
 
Rossana Casaretti
No Relationships to Disclose
 
Ilaria Bernardini
No Relationships to Disclose
 
Giovanna Bellotti
No Relationships to Disclose
 
Giovanni Luca Frassineti
No Relationships to Disclose
 
Francesca Di Fabio
No Relationships to Disclose
 
Michele Aieta
No Relationships to Disclose
 
Michele Ghidini
No Relationships to Disclose
 
Chiara Trentin
No Relationships to Disclose
 
Giovanni Gerardo Cardellino
No Relationships to Disclose
 
Erika Gervasi
No Relationships to Disclose
 
Alessandra Romagnani
No Relationships to Disclose
 
Saverio Cinieri
No Relationships to Disclose
 
Nicola Normanno
Honoraria - AstraZeneca; Biocartis; Illumina; Incyte; Lilly; Merck Serono; MSD; MSD; Thermo Fisher Scientific
Consulting or Advisory Role - AstraZeneca; Bayer; Biocartis; Incyte; Novartis; Roche
Research Funding - AstraZeneca (Inst); Biocartis (Inst); Illumina (Inst); Incyte (Inst); Merck Serono (Inst); Qiagen (Inst); Roche (Inst); Thermo Fisher Scientific (Inst)
Travel, Accommodations, Expenses - Merck Serono
 
Carmine Pinto
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Incyte; Ipsen; Janssen; Merck Serono; MSD; Novartis; Roche; SERVIER
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Incyte; Ipsen; Janssen; Merck Serono; MSD; Novartis; Pierre Fabre; Roche; SERVIER
Research Funding - AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; Lilly; Roche